Insider Transactions in Q4 2021 at Gossamer Bio, Inc. (GOSS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 25
2021
|
Richard Aranda Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,377
-1.08%
|
$28,524
$12.25 P/Share
|
|
Oct 25
2021
|
Laura Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,377
-2.43%
|
$28,524
$12.25 P/Share
|
|
Oct 25
2021
|
Caryn Peterson EVP, Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
2,377
-3.18%
|
$28,524
$12.25 P/Share
|